Form 4: Teladoc Director Buys 10,000 Shares in Open Market

Teladoc Health Director Kenneth H. Paulus acquired 10,000 shares of common stock at $6.94 per share through a pre-arranged Rule 10b5-1 trading plan.

Summary

• Kenneth H. Paulus, a Director of Teladoc Health, Inc. (TDOC), purchased 10,000 shares of the company's common stock.
• The transaction occurred on November 14, 2025, at a price of $6.94 per share.
• This acquisition was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Paulus on August 15, 2025.
• Following this transaction, Mr. Paulus beneficially owns 10,000 shares of Teladoc Health common stock.
• The total value of the shares acquired in this transaction is $69,400.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. Insider buying, especially by a director, generally indicates confidence in the company's future. While the amount is not massive, it's a direct financial commitment.

Positives

• A Director's purchase of company stock signals confidence in the company's future prospects and valuation.
• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned purchase rather than a reaction to immediate news, which can suggest a long-term investment perspective.

Future Outlook

This filing does not contain explicit forward-looking statements or guidance regarding the company's future performance.

Industry Context

Insider buying, particularly by a director, is often viewed by the market as a positive signal, suggesting that those closest to the company believe its stock is undervalued or has strong growth potential. In the telehealth industry, which has seen significant shifts and revaluations, such a purchase could be interpreted as a vote of confidence in Teladoc's strategic direction and long-term viability.

Comparison to Industry Standards

• Insider buying activity is a common occurrence across all industries. While the specific amount of 10,000 shares is not exceptionally large compared to the total outstanding shares of a company like Teladoc, it represents a direct financial commitment from a board member.
• Compared to other telehealth companies, insider buying can be a differentiating factor, especially if it contrasts with insider selling at competitors or indicates a belief in Teladoc's specific market position amidst broader industry challenges.

Related Party Transactions

• The acquisition of 10,000 shares of common stock by Director Kenneth H. Paulus is a related party transaction, as it involves a company insider purchasing securities from the issuer.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator, potentially increasing confidence in the company's stock and management's belief in its value.
• Employees might interpret this as a sign of stability and positive outlook from leadership.

Key Dates

Recommendation

The insider purchase by a director is a positive signal, suggesting confidence in Teladoc Health's future. However, a single transaction, while noteworthy, typically warrants a 'hold' recommendation rather than a 'strong buy' unless accompanied by other significant positive developments or a larger pattern of insider accumulation. Investors should consider this alongside broader financial performance and market conditions.

Keywords

Teladoc Health, TDOC, Insider Trading, Form 4, Stock Purchase, Director, Kenneth H. Paulus, Rule 10b5-1